Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies ; volume:69 ; number:5 ; day:9 ; month:3 ; year:2020 ; pages:683-687 ; date:5.2020
Cancer immunology immunotherapy ; 69, Heft 5 (9.3.2020), 683-687, 5.2020
- Urheber
-
Kerepesi, Csaba
Bakacs, Tibor
Moss, Ralph W.
Slavin, Shimon
Anderson, Colin C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-020-02543-6
- URN
-
urn:nbn:de:101:1-2020070513531601142980
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
05.11.2025, 16:02 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kerepesi, Csaba
- Bakacs, Tibor
- Moss, Ralph W.
- Slavin, Shimon
- Anderson, Colin C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
Managing immune-related adverse events in oncology
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
The immune-related role of BRAF in melanoma
Immune-related biomarkers in triple-negative breast cancer
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
Managing immune-related adverse events in oncology
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
The immune-related role of BRAF in melanoma
Immune-related biomarkers in triple-negative breast cancer
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
A Toolbox of Potential Immune-Related Therapies for Inflammatory Cardiomyopathy
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
Managing immune-related adverse events in oncology
Immune-related adverse event in the emergency department: methodology of the immune-related emergency disposition index (IrEDi)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
The immune-related role of BRAF in melanoma
Immune-related biomarkers in triple-negative breast cancer
Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors